APA (7th ed.) Citation

Goldschmidt, H., Dimopoulos, M. A., Rajkumar, S. V., Weisel, K., Moreau, P., Chng, W. J., . . . Mateos, M. (2020). Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma. Leukemia, 34(11), . https://doi.org/10.1038/s41375-020-0819-8

Chicago Style (17th ed.) Citation

Goldschmidt, Hartmut, et al. "Deepening Responses Associated with Improved Progression-free Survival with Ixazomib Versus Placebo as Posttransplant Maintenance in Multiple Myeloma." Leukemia 34, no. 11 (2020). https://doi.org/10.1038/s41375-020-0819-8.

MLA (9th ed.) Citation

Goldschmidt, Hartmut, et al. "Deepening Responses Associated with Improved Progression-free Survival with Ixazomib Versus Placebo as Posttransplant Maintenance in Multiple Myeloma." Leukemia, vol. 34, no. 11, 2020, https://doi.org/10.1038/s41375-020-0819-8.